BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38540371)

  • 1. Gene Expression Analysis for Uterine Cervix and Corpus Cancer Characterization.
    Almorox L; Antequera L; Rojas I; Herrera LJ; Ortuño FM
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.
    Mandai M; Konishi I; Koshiyama M; Komatsu T; Yamamoto S; Nanbu K; Mori T; Fukumoto M
    Cancer; 1995 May; 75(10):2523-9. PubMed ID: 7736397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtypes of cervical adenosquamous carcinomas classified by EpCAM expression related to radiosensitivity.
    Imadome K; Iwakawa M; Nakawatari M; Fujita H; Kato S; Ohno T; Nakamura E; Ohkubo Y; Tamaki T; Kiyohara H; Imai T
    Cancer Biol Ther; 2010 Nov; 10(10):1019-26. PubMed ID: 20855955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class I chain-related gene A (MICA) polymorphism and the different histological types of cervical cancer.
    Chen JR; Lee YJ; Chen T; Wang KL; Dang CW; Chang SC; Liu HF; Yang YC
    Neoplasma; 2005; 52(5):369-73. PubMed ID: 16151576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.
    Wang R; van Leeuwen RW; Boers A; Klip HG; de Meyer T; Steenbergen RD; van Criekinge W; van der Zee AG; Schuuring E; Wisman GB
    Oncotarget; 2016 Dec; 7(49):80735-80750. PubMed ID: 27738327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling in two morphologically different uterine cervical carcinoma cell lines derived from a single donor using a human cancer cDNA array.
    Fujimoto T; Nishikawa A; Iwasaki M; Akutagawa N; Teramoto M; Kudo R
    Gynecol Oncol; 2004 May; 93(2):446-53. PubMed ID: 15099960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression.
    Chao A; Wang TH; Lee YS; Hsueh S; Chao AS; Chang TC; Kung WH; Huang SL; Chao FY; Wei ML; Lai CH
    Int J Cancer; 2006 Jul; 119(1):91-8. PubMed ID: 16450401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive profile and contrastive analysis of circular RNA expression in cervical squamous carcinoma and adenocarcinoma.
    Luo H; Zhu Y; Wang J; Wang Y; Wei L
    PeerJ; 2023; 11():e14759. PubMed ID: 36721776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the ARID-1 alpha expressions in squamous and adenosquamous carcinomas of uterine cervix.
    Solakoglu Kahraman D; Diniz G; Sayhan S; Ayaz D; Uncel M; Karadeniz T; Akman T; Ozdemir A
    APMIS; 2015 Oct; 123(10):847-50. PubMed ID: 26303865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Contag SA; Gostout BS; Clayton AC; Dixon MH; McGovern RM; Calhoun ES
    Gynecol Oncol; 2004 Dec; 95(3):610-7. PubMed ID: 15581972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of uterine corpus tumor invasion in early-stage cervical cancer.
    Matsuo K; Machida H; Blake EA; Takiuchi T; Mikami M; Roman LD
    Eur J Surg Oncol; 2017 Apr; 43(4):725-734. PubMed ID: 28215507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiation.
    Rose PG; Java JJ; Whitney CW; Stehman FB; Lanciano R; Thomas GM
    Gynecol Oncol; 2014 Nov; 135(2):208-12. PubMed ID: 25152438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue expression of human epididymal secretory protein 4 may be useful in the differential diagnosis of uterine cervical tumors.
    Diniz G; Karadeniz T; Sayhan S; Akata T; Aydiner F; Ayaz D; Solakoglu Kahraman D; Akman T
    Ginekol Pol; 2017; 88(2):51-55. PubMed ID: 28326512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer.
    Zhang Z; Borecki I; Nguyen L; Ma D; Smith K; Huettner PC; Mutch DG; Herzog TJ; Gibb RK; Powell MA; Grigsby PW; Massad LS; Hernandez E; Judson PL; Swisher EM; Crowder S; Li J; Gerhard DS; Rader JS
    Cancer Res; 2007 Dec; 67(23):11202-8. PubMed ID: 18056445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers.
    Sano T; Shimooka H; Weixa P; Segawa A; Jian Z; Motegi A; Nakayama H; Oyama T; Nakajima T
    Pathol Int; 2004 Oct; 54(10):743-50. PubMed ID: 15482563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
    Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
    J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis.
    Zhou J; Wu SG; Sun JY; Li FY; Lin HX; Chen QH; He ZY
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):115-122. PubMed ID: 27646608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric-type cervical adenocarcinoma with squamous differentiation: buried in adenosquamous carcinomas?
    Yoshida H; Naka T; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
    Virchows Arch; 2021 Aug; 479(2):407-412. PubMed ID: 33404855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.